Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Longhu Zhou"'
Autor:
Longhu Zhou, Hongwang Zhang, Chengwei Li, Coralie De Schutter, Ozkan Sari, Seema Mengshetti, Shaoman Zhou, Mahesh Kasthuri, Steven J. Coats, Raymond F. Schinazi, Franck Amblard
Publikováno v:
ACS Omega, Vol 7, Iss 1, Pp 1452-1461 (2021)
Externí odkaz:
https://doaj.org/article/e014eeef2887439f89555878649fce6a
Autor:
Franck Amblard, Julia C. LeCher, Ramyani De, Shu Ling Goh, Chengwei Li, Mahesh Kasthuri, Nicolas Biteau, Longhu Zhou, Zahira Tber, Jessica Downs-Bowen, Keivan Zandi, Raymond F. Schinazi
Publikováno v:
Pharmaceuticals, Vol 15, Iss 9, p 1144 (2022)
Coronavirus disease 2019 (COVID-19) is an emerging global pandemic with severe morbidity and mortality caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Molnupiravir, an ester prodrug form of N4-hydroxycytidine (NHC), was re
Externí odkaz:
https://doaj.org/article/5b28f39250b449959a136cc3c1d06f07
Autor:
Joseph A Hollenbaugh, Jadd Shelton, Sijia Tao, Sheida Amiralaei, Peng Liu, Xiao Lu, Russell W Goetze, Longhu Zhou, James H Nettles, Raymond F Schinazi, Baek Kim
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169052 (2017)
SAMHD1 hydrolyzes 2'-deoxynucleoside-5'-triphosphates (dNTPs) into 2'-deoxynucleosides and inorganic triphosphate products. In this paper, we evaluated the impact of 2' sugar moiety substitution for different nucleotides on being substrates for SAMHD
Externí odkaz:
https://doaj.org/article/7585f5c3a1dc4457859860a505db1ff0
Autor:
Franck, Amblard, Julia C, LeCher, Ramyani, De, Shu Ling, Goh, Chengwei, Li, Mahesh, Kasthuri, Nicolas, Biteau, Longhu, Zhou, Zahira, Tber, Jessica, Downs-Bowen, Keivan, Zandi, Raymond F, Schinazi
Publikováno v:
Pharmaceuticals (Basel, Switzerland). 15(9)
Coronavirus disease 2019 (COVID-19) is an emerging global pandemic with severe morbidity and mortality caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Molnupiravir, an ester prodrug form of
Autor:
Rebeca Rocha, Longhu Zhou, Marília Zaluar P. Guimarães, Christina Gavegnano, Juliana L. Del Sarto, Leda Bassit, Franck Amblard, Vivian Vasconcelos Costa, Bruno V. S. Valiate, Isabella G. Olmo, Carolina da S. G. Pedrosa, Mauro M. Teixeira, Fabiola M. Ribeiro, Stevens K. Rehen, Bryan Cox, Celso Martins Queiroz-Junior, Raymond F. Schinazi
Publikováno v:
Antiviral research. 180
Zika virus (ZIKV) has gained a lot of attention in the past few years due to its rapid spread worldwide and its close association to severe neurological outcomes, such as microcephaly and Guillain-Barre syndrome. In this study, the in vitro and in vi
Autor:
Sijia, Tao, Longhu, Zhou, Hongwang, Zhang, Shaoman, Zhou, Sheida, Amiralaei, Jadd, Shelton, Maryam, Ehteshami, Yong, Jiang, Franck, Amblard, Steven J, Coats, Raymond F, Schinazi
Publikováno v:
Nucleosides Nucleotides Nucleic Acids
β-D-2’-C-Methyl-2,6-diaminopurine ribonucleoside (2’-C-Me-DAPN) phosphoramidate prodrug (DAPN-PD) is a selective hepatitis C virus inhibitor that is metabolized intracellularly into two active metabolites: 2’-C-Methyl-DAPN triphosphate (2’-C
Autor:
Hongwang Zhang, Franck Amblard, Keivan Zandi, Raymond F. Schinazi, Sarah Amichai, Bryan Cox, Longhu Zhou
Publikováno v:
Bioorg Med Chem Lett
Exploration of the chemical space of known influenza polymerase PB2 inhibitor Pimodivir, was performed by our group. We synthesized and identified compounds 16a and 16b, two novel thienopyrimidine derivatives displaying anti-influenza A activity in t
Autor:
Tamara R. McBrayer, Biing Y. Lin, Kiran Verma, Ozkan Sari, Olivia Ollinger Russell, Judy Pattassery, Yong Jiang, Maria Luz G. Pascual, Steven J. Coats, Seema Mengshetti, Leda Bassit, Jong Hyun Cho, Reuben Ovadia, Sijia Tao, Sam Lee, Mahesh Kasthuri, Robert A. Domaoal, Tony Whitaker, Coralie De Schutter, Raymond F. Schinazi, Longhu Zhou, Lothar Uher, Hongwang Zhang, Maryam Ehteshami, Franck Amblard
Publikováno v:
J Med Chem
Hepatitis C virus (HCV) nucleoside inhibitors display pan-genotypic activity, a high barrier to the selection of resistant virus, and are some of the most potent direct-acting agents with durable sustained virologic response in humans. Herein, we rep
Autor:
Franck Amblard, Tony Whitaker, Sheida Amiralaei, Biing Lin, Jadd R. Shelton, Hongwang Zhang, Sijia Tao, Longhu Zhou, Robert A. Domaoal, Ahmed Khalil, Jong Hyun Cho, Steven J. Coats, Maryam Ehteshami, Tugba Ozturk, Xiao Lu, Richard A. Stanton, Sam S. Lee, Justin E. Suesserman, Raymond F. Schinazi
Publikováno v:
Antimicrobial Agents and Chemotherapy. 60:4659-4669
Ribonucleoside analog inhibitors (rNAI) target the hepatitis C virus (HCV) RNA-dependent RNA polymerase nonstructural protein 5B (NS5B) and cause RNA chain termination. Here, we expand our studies on β- d -2′- C -methyl-2,6-diaminopurine-ribonucle
Autor:
Steven J. Coats, Hongwang Zhang, Maryam Ehteshami, Philip Tharnish, Jong Hyun Cho, Franck Amblard, Tamara R. McBrayer, Longhu Zhou, Sijia Tao, Tony Whitaker, Raymond F. Schinazi
Publikováno v:
ACS Medicinal Chemistry Letters. 7:17-22
A variety of 2,6-modified purine 2'-C-methylribonucleosides and their phosphoramidate prodrugs were synthesized and evaluated for inhibition of HCV RNA replication in Huh-7 cells and for cytotoxicity in various cell lines. Cellular pharmacology and H